Glycated albumin as a marker of glycemia in diabetes and its vascular complications

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2015, Vol 69, Issue 0

Abstract

Effective glycemic control is very important to prevent the onset and the progression of chronic complications in diabetic patients. It is known that glycation of various proteins is increased in diabetic patients compared with non-diabetics. Among these glycated proteins, glycated hemoglobin (HbA1c) is commonly used as a gold standard index of glycemic control in the clinical setting. However, it can be unreliable in conditions affecting the lifespan of erythrocytes (120 days) as well as in the clinical state in which glycemic control alleviates or deteriorates in a short period. By overcoming the shortcomings of HbA1c, glycated albumin (GA) has gained interest as a useful index for an intermediate glycation period (2 weeks) and pathogenic protein.After giving a brief overview of the key role of HbA1c as a long-term glycemic marker, this review focuses on (a) glycation of human albumin and its main properties, (b) methods of GA determination, (c) the recent clinical status of GA as a glycemic index in diabetic patients and its association with vascular complications. Finally, conditions with a possible inaccurate GA level are also mentioned.

Authors and Affiliations

Maria Warwas, Ewa Żurawska-Płaksej, Dagmara Ciężka, Agnieszka Piwowar

Keywords

Related Articles

Lung cancer stem cells – the role in pathogenesis and progressive growth of cancer

Lung cancer is the main cause of cancer death worldwide. Rapid accurate diagnosis, recognition of risk factors and improvement of treatment efficacy represent the main challenges. An advanced stage of the disease at the...

Szkodliwe działanie wanadu na układ pokarmowy i moczowo-płciowy oraz jego wpływ na płodność i wady rozwojowe płodu

Vanadium is a transition metal that has a unique and beneficial effect on both humans and animals. For many years, studies have suggested that vanadium is an essential trace element. Its biological properties are of inte...

Metformina kluczem do alternatywnej aktywacji mikrogleju?

Wyniki ostatnich badań wskazują, że metformina (niezależnie od działania antyhiperglikemicznego) może hamować procesy neurozapalne i bezpośrednio wpływać na ośrodkowy układ nerwowy. Mechanizmy molekularne, przez które me...

Zastosowanie hodowli komórkowych, płynów ustrojowych i tkanek w onkoproteomice

Badania proteomiczne oparte na technologii spektrometrii masowej umożliwiają kompleksową analizę białek, badanie ich aktywności oraz wzajemnych oddziaływań. W ostatnich latach proteomika przestała funkcjonować jedynie ja...

The diagnostic importance of the new marker KIM-1 in kidney damage

In recent years, the rapid development of scientific research led to the introduction of strategies based on new markers that allow for estimation of the latent disease period before the clinical symptoms of actual kidne...

Download PDF file
  • EP ID EP67698
  • DOI -
  • Views 148
  • Downloads 0

How To Cite

Maria Warwas, Ewa Żurawska-Płaksej, Dagmara Ciężka, Agnieszka Piwowar (2015). Glycated albumin as a marker of glycemia in diabetes and its vascular complications. Advances in Hygiene and Experimental Medicine, 69(0), 638-648. https://europub.co.uk./articles/-A-67698